Skip to main content
OpenTrials

Clinical trial condition

Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)

Explore clinical trials studying Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) trial results

Completed

Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

NCT03249870

Conditions
Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP), Chromosome Aberrations, Hematologic Diseases, +14 more
Locations
  • CH Amiens sud Amiens, France
  • CHU Angers Angers, France
  • CH Victor Dupouy Argenteuil, France
  • CH cote basque Bayonne, France
View all 41 locations
View Trial Details

Related conditions